يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"Tore Kvien"', وقت الاستعلام: 0.96s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: Service de Rhumatologie [CHU Cochin], Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Cochin [AP-HP], Département de Rhumatologie[Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Hôpital Lapeyronie, Institut de Génétique Moléculaire de Montpellier ( IGMM ), Université de Montpellier ( UM ) -Centre National de la Recherche Scientifique ( CNRS ), Service de Rhumatologie [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Pitié-Salpêtrière [APHP], Institut de biologie moléculaire et cellulaire ( IBMC ), Université de Strasbourg ( UNISTRA ) -Centre National de la Recherche Scientifique ( CNRS ), CHU Strasbourg, Immunologie des Maladies Virales et Autoimmunes ( IMVA - U1184 ), Université Paris-Sud - Paris 11 ( UP11 ) -Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Hôpital Bicêtre, Université Paris-Sud - Paris 11 ( UP11 ) -Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Bicêtre, Service de Rhumatologie [CHU Pellegrin], Groupe hospitalier Pellegrin, Immunology from Concept and Experiments to Translation ( ImmunoConcept ), Université de Bordeaux ( UB ) -Centre National de la Recherche Scientifique ( CNRS ), Service de rhumatologie [CHU Cochin], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Lapeyronie, Institut de Génétique Moléculaire de Montpellier (IGMM), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Service de rhumatologie [CHU Pitié Salpêtrière] (GRC-08 EEMOIS), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut de biologie moléculaire et cellulaire (IBMC), Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS), Immunologie des Maladies Virales et Autoimmunes (IMVA - U1184), Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre, Immunology from Concept and Experiments to Translation (ImmunoConcept), Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), CHU Pitié-Salpêtrière [AP-HP], Université Paris-Sud - Paris 11 (UP11)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Rheumatology, Smolen, Josef S, Landewé, Robert, Bijlsma, Johannes, Burmester, Gerd, Chatzidionysiou, Katerina, Dougados, Maxime, Nam, Jackie, Ramiro, Sofia, Voshaar, Marieke, van Vollenhoven, Ronald, Finckh, Axel, Gabay, Cem, AII - Inflammatory diseases, Epidemiology and Data Science, APH - Methodology, Ethics, Law & Medical humanities, Service de Rhumatologie [CHU Pitié Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)

    المصدر: Annals of the Rheumatic Diseases
    Annals of the Rheumatic Diseases, BMJ Publishing Group, 2017, 76 (6), pp.960-977. 〈10.1136/annrheumdis-2016-210715〉
    Annals of the Rheumatic Diseases, BMJ Publishing Group, 2017, 76 (6), pp.960-977. ⟨10.1136/annrheumdis-2016-210715⟩
    Annals of the Rheumatic Diseases, 2017, 76 (6), pp.960-977. ⟨10.1136/annrheumdis-2016-210715⟩
    Annals of the Rheumatic Diseases, 76(6), 960-977
    Annals of the Rheumatic Diseases, 76(6), 960-977. BMJ Publishing Group
    Annals of the Rheumatic Diseases, Vol. 76, No 6 (2017) pp. 960-977
    Smolen, J S, Landewé, R, Bijlsma, J, Burmester, G, Chatzidionysiou, K, Dougados, M, Nam, J, Ramiro, S, Voshaar, M, Van Vollenhoven, R, Aletaha, D, Aringer, M, Boers, M, Buckley, C D, Buttgereit, F, Bykerk, V, Cardiel, M, Combe, B, Cutolo, M, Van Eijk-Hustings, Y, Emery, P, Finckh, A, Gabay, C, Gomez-Reino, J, Gossec, L, Gottenberg, J E, Hazes, J M W, Huizinga, T, Jani, M, Karateev, D, Kouloumas, M, Kvien, T, Li, Z, Mariette, X, McInnes, I, Mysler, E, Nash, P, Pavelka, K, Poór, G, Richez, C, Van Riel, P, Rubbert-Roth, A, Saag, K, Da Silva, J, Stamm, T, Takeuchi, T, Westhovens, R, De Wit, M & Van Der Heijde, D 2017, ' EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs : 2016 update ', Annals of the Rheumatic Diseases, vol. 76, no. 6, pp. 960-977 . https://doi.org/10.1136/annrheumdis-2016-210715
    Annals of the Rheumatic Diseases, 76, 6, pp. 960-977
    Annals of the Rheumatic Diseases, 76, 960-977
    Smolen, J S, Landewe, R, Bijlsma, J W J, Burmester, G R, Chatzidionysiou, K, Combe, B, Dougados, M, Nam, J L, Ramiro, S, Scholte, M, van Vollenhoven, R F, Aletaha, D, Aringer, M, Boers, M, Buckley, C, Bykerk, V, Buttgereit, F, Cardiel, M, Cutolo, M, van Eijk-Hustings, Y, Emery, P, Finckh, A, Gabay, C, Gómez-Reino, J J, Gossec, L, Gottenberg, J-E, Hazes, M, Huizinga, T, Jani, M, Karateev, D, Kouloumas, M, Kvien, T K, Li, Z, Mariette, X, McInnes, I B, Mysler, E, Nash, P, Pavelka, K, Poor, G, Richez, C, van Riel, P, Rubbert-Roth, A, Saag, K, Da Silva, J, Stamm, T, Takeuchi, T, Westhovens, R, de Wit, M & van der Heijde, D 2017, ' EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 Update ', Annals of the rheumatic diseases, vol. 76, no. 6, pp. 960-977 . https://doi.org/10.1136/annrheumdis-2016-210715

    مصطلحات موضوعية: Glucocorticoids/therapeutic use, Time Factors, Protein Kinase Inhibitors/therapeutic use, medicine.medical_treatment, Antirheumatic Agents/therapeutic use, DMARDs (biologic), PLACEBO-CONTROLLED TRIAL, law.invention, ACUTE-PHASE REACTANTS, Arthritis, Rheumatoid, 0302 clinical medicine, Randomized controlled trial, law, Immunology and Allergy, 030212 general & internal medicine, Janus Kinases/antagonists & inhibitors, Certolizumab pegol, INTERLEUKIN-6 RECEPTOR INHIBITION, skin and connective tissue diseases, ddc:616, Drug Substitution, DOSE GLUCOCORTICOID THERAPY, Antibodies, Monoclonal, ADALIMUMAB PLUS METHOTREXATE, RANDOMIZED CONTROLLED-TRIAL, 3. Good health, Antirheumatic Agents, TREAT-TO-TARGET, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, Arthritis, Rheumatoid/drug therapy, Rheumatoid arthritis, Drug Therapy, Combination, DMARDs (synthetic), medicine.drug, musculoskeletal diseases, medicine.medical_specialty, Methotrexate/therapeutic use, Immunology, Antibodies, Monoclonal/therapeutic use, Rheumatoid Arthritis, General Biochemistry, Genetics and Molecular Biology, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], [ SDV.MHEP.RSOA ] Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, 03 medical and health sciences, Rheumatology, RAPID RADIOGRAPHIC PROGRESSION, medicine, Humans, Disease-modifying antirheumatic drug, Intensive care medicine, Disease Activity, Glucocorticoids, Protein Kinase Inhibitors, Janus Kinases, STANDARDIZED OPERATING PROCEDURES, 030203 arthritis & rheumatology, business.industry, Tumor Necrosis Factor-alpha, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Abatacept, Evidence-based medicine, medicine.disease, Treatment, Methotrexate, Patient Participation, business, Rheumatism, CARDIOVASCULAR RISK-MANAGEMENT

    وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

  3. 3
    دورية أكاديمية

    المؤلفون: Till Uhlig, Rikke Moe, Tore Kvien

    المصدر: Springer, PharmacoEconomics. 32(9):841-851

  4. 4
    دورية أكاديمية

    المصدر: Springer, Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement. 40(3):285-298

  5. 5
  6. 6
  7. 7
  8. 8
    دورية أكاديمية